Abstract:Heparanase (HPSE) is an endo-acting beta-glucuronidase and the only known enzyme responsible for the regulation of extracellular heparan sulfate (HS) structures, a glycosaminoglycan (GAG) occurring in conjugation with a protein class called heparan sulfate proteoglycans (HSPGs) in the extracellular matrix (ECM). The enzyme is found to be significantly upregulated in aggressive cancer types aiding cell proliferation by increased degradation of HS. Inhibition of HPSE reduces cancer growth making it an interesting druggable target for cancer treatment and diagnostics. Only few of the known efficient HPSE inhibitors have progressed through clinical studies and none of them has been approved yet. We here present the synthesis of three cyclophellitol scaffolds, based on known mechanism-based inhibitors of HPSE. These novel scaffolds are amenable to facile elaboration via copper-catalysed azide-alkyne cycloadditions to aid in exploring the structure-activity relationship for selective inhibitors of HPSE.

What problem does this paper attempt to address?

This paper focuses on the development of selective glucuronidase inhibitors, which have potential for the treatment of cancer and other diseases. Researchers synthesized azadispiro and epoxy carbocycles containing alkynyl and diazonium groups, which serve as the basis for known mechanism-based inhibitors. They designed these novel scaffolds with the aim of further modification through click chemistry reactions to explore the structure-activity relationship against glucuronidase and improve selectivity. The article points out that heparanase (HPSE) is an endoglycosidase of the β-glucuronidase type responsible for regulating extracellular heparan sulfate (HS) structure and participating in various physiological functions. In certain invasive cancers, increased expression of this enzyme promotes cell proliferation and accelerates tumor growth. Although several inhibitors have entered clinical trials, no drugs have been approved for clinical use at present. The researchers synthesized cyclohexene intermediates with different protecting groups through a series of chemical reactions, and then prepared glucuronic cyclopentenone scaffolds containing alkynyl and diazonium groups from these intermediates. These scaffolds can be conveniently further modified through click chemistry reactions to test inhibition efficacy and selectivity against HPSE. They particularly focused on modifying the scaffold at the 4-position while preserving the conformational path required for the molecular capture of the 4H3 transition state. The paper describes in detail the stepwise synthesis of the target compounds starting from D-xylose, including protecting group selection, deprotection, coupling reactions, and cyclization. The authors also investigated the impact of different protecting groups on the reactions, such as triphenylmethyl, benzyl, and tert-butyldimethylsilyl, and identified the optimal protection strategy. The study encountered some challenges, such as protecting group migration, solvent selection, and reaction condition optimization. However, the glucuronic cyclopentenone imine containing alkynyl and diazonium groups was successfully synthesized, which can serve as a substrate for click chemistry reactions to further explore its inhibitory activity and selectivity against HPSE. In summary, this paper aims to develop novel and modifiable glucuronidase inhibitor precursors through synthetic chemistry methods, in order to improve the bioavailability and selectivity of drugs and provide new strategies for the treatment of cancer and other diseases.

Synthesis of alkyne- and azide-functionalised aziridine and epoxide carbocycles for development of selective glucuronidase mechanism-based inhibitors

A Universal and Modular Scaffold for Heparanase Activatable Probes and Drugs

Complex Inhibitory Mechanism of Glycomimetics with Heparanase.

Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo

Abstract 3105: Design principle of heparanase inhibitors: A combined in vitro and in silico study

Design Principle of Heparanase Inhibitors: A Combined In Vitro and In Silico Study

Synthesis of competitive and noncompetitive inhibitors of alpha‐glucosidase and anticancer agents.

Chemical toolbox to interrogate Heparanase-1 activity

Chemoenzymatic synthesis of sulfur-linked sugar polymers as heparanase inhibitors

Synthesis and investigation of novel 6-(1,2,3-triazol-4-yl)-4-aminoquinazolin derivatives possessing hydroxamic acid moiety for cancer therapy.

Concise Chemoenzymatic Synthesis of Heparan Sulfate Analogues As Potent BACE-1 Inhibitors.

Synthesis of Novel Glycolipid Mimetics of Heparan Sulfate and Their Application in Colorectal Cancer Treatment in a Mouse Model

An Enantioselective Aminocatalytic Cascade Reaction Affording Bioactive Hexahydroazulene Scaffolds

N‐Methyl‐N‐Alkylaminocyclopentanes: Powerful and Selective β‐D‐Glucocerebrosidase Inhibitors

Synthesis, α-Glucosidase Inhibition, Anticancer, DFT and Molecular Docking Investigations of Pyrazole Hydrazone Derivatives

Ultrasound Assisted Synthesis of Pyran Derivatives Catalysed by Uranyl Nitrate and Their Molecular Docking Against Glycogen Synthase Kinase-3 Beta Receptor

Use of protease substrate specificity screening in the rational design of selective protease inhibitors with unnatural amino acids: Application to HGFA, matriptase, and hepsin

An efficient methodological approach for synthesis of selenopyridines: generation, reactions, anticancer activity, EGFR inhibitory activity and molecular docking studies

One-pot synthesis of fused isoxazolo[4′,5′:4,5]thiopyrano[2,3- d ]pyrimidines as potent EGFR targeting anti-lung cancer agents

Antitumor activity and structure-activity relationship of heparanase inhibitors: Recent advances

One-pot Construction of Functionalized Aziridines and Maleimides Via a Novel Pseudo-Knoevenagel Cascade Reaction